CD38 expression does not change in B-cell chronic lymphocytic leukemia

被引:18
作者
D'Arena, G [1 ]
Nunziata, G [1 ]
Coppola, G [1 ]
Vigilotti, ML [1 ]
Tartarone, A [1 ]
Carpinelli, N [1 ]
Matera, R [1 ]
Bisogno, RC [1 ]
Pistolese, G [1 ]
Di Renzo, N [1 ]
机构
[1] CROB Reg Hosp, Hematol Oncol Unit, Rionero In Vulture, Italy
关键词
D O I
10.1182/blood-2002-07-2249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3052 / 3053
页数:2
相关论文
共 10 条
[1]   CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia [J].
Chevallier, P ;
Penther, D ;
Avet-Loiseau, H ;
Robillard, N ;
Ifrah, N ;
Mahé, B ;
Hamidou, M ;
Maisonneuve, H ;
Moreau, P ;
Jardel, H ;
Harousseau, JL ;
Bataille, R ;
Garand, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (01) :142-150
[2]   CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia [J].
D'Arena, G ;
Musto, P ;
Cascavilla, N ;
Dell'Olio, M ;
Di Renzo, N ;
Perla, G ;
Savino, L ;
Carotenuto, M .
LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :109-114
[3]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[4]   Clinical significance of CD38 expression in chronic lymphocytic leukemia [J].
Del Poeta, G ;
Maurillo, L ;
Venditti, A ;
Buccisano, F ;
Epiceno, AM ;
Capelli, G ;
Tamburini, A ;
Suppo, G ;
Battaglia, A ;
Del Principe, MI ;
Del Moro, B ;
Masi, M ;
Amadori, S .
BLOOD, 2001, 98 (09) :2633-2639
[5]   Impact of cryopreservation on B cell chronic lymphocytic leukaemia phenotype [J].
Deneys, V ;
Thiry, V ;
Hougardy, N ;
Mazzon, AM ;
Leveugle, P ;
De Bruyère, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 228 (1-2) :13-21
[6]   CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia [J].
Dürig, J ;
Naschar, M ;
Schmücker, U ;
Renzing-Köhler, K ;
Hölter, T ;
Hüttmann, A ;
Dührsen, U .
LEUKEMIA, 2002, 16 (01) :30-35
[7]   CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease [J].
Hamblin, TJ ;
Orchard, JA ;
Ibbotson, RE ;
Davis, Z ;
Thomas, PW ;
Stevenson, FK ;
Oscier, DG .
BLOOD, 2002, 99 (03) :1023-1029
[8]   Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia [J].
Heintel, D ;
Schwarzinger, I ;
Chizzali-Bonfadin, C ;
Thalhammer, R ;
Schwarzmeier, J ;
Fritzer-Szekeres, M ;
Weltermann, A ;
Simonitsch, I ;
Lechner, K ;
Jaeger, U .
LEUKEMIA & LYMPHOMA, 2001, 42 (06) :1315-1321
[9]   CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia [J].
Ibrahim, S ;
Keating, M ;
Do, KA ;
O'Brien, S ;
Huh, YO ;
Jilani, I ;
Lerner, S ;
Kantarjian, HM ;
Albitar, M .
BLOOD, 2001, 98 (01) :181-186
[10]   Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia [J].
Morabito, F ;
Mangiola, M ;
Oliva, B ;
Stelitano, C ;
Callea, V ;
Deaglio, S ;
Iacopino, P ;
Brugiatelli, M ;
Malavasi, F .
LEUKEMIA RESEARCH, 2001, 25 (11) :927-932